{"nctId":"NCT00348348","briefTitle":"A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis","startDateStruct":{"date":"2006-06"},"conditions":["Acute Bacterial Conjunctivitis"],"count":1161,"armGroups":[{"label":"Moxifloxacin solution","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Moxifloxacin solution"]},{"label":"Besifloxacin Suspension","type":"EXPERIMENTAL","interventionNames":["Drug: Besifloxacin"]}],"interventions":[{"name":"Besifloxacin","otherNames":[]},{"name":"Moxifloxacin solution","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye.\n\nExclusion Criteria:\n\n* Pregnant or nursing females.\n* Use of any antibiotic within 72 hours of enrollment.\n* Any disease conditions that could interfere with the safety and efficacy evaluations of the study drug.\n* Participation in an ophthalmic drug or device research study within 30 days prior to entry into this study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Year","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinical Resolution","description":"Resolution of conjunctival discharge and bulbar conjunctival injection. (mITT, culture confirmed, as treated)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"167","spread":null},{"groupId":"OG001","value":"147","spread":null}]}]}]},{"type":"PRIMARY","title":"Microbial Eradication","description":"eradication of baseline bacterial infection. modified intent to treat (mITT), culture confirmed, as treated","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"256","spread":null},{"groupId":"OG001","value":"235","spread":null}]}]}]},{"type":"SECONDARY","title":"Clinical Resolution","description":"Clinical resolution of conjunctival discharge and bulbar conjunctival injection, modified intent to treat (mITT), culture confirmed, as treated","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"236","spread":null},{"groupId":"OG001","value":"213","spread":null}]}]}]},{"type":"SECONDARY","title":"Microbial Eradication","description":"Microbial eradication of baseline bacterial infection. modified intent to treat (mITT), culture confirmed, as treated","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"238","spread":null},{"groupId":"OG001","value":"220","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":579},"commonTop":[]}}}